First test of virus shield for tiny transplant patients

NCT ID NCT07199465

Summary

This study is testing a drug called letermovir to prevent cytomegalovirus (CMV) infection in children and teens who have received a kidney transplant and weigh less than 88 pounds. Researchers want to understand how the child's body processes the drug and check if it is safe and well-tolerated. The study will include about 40 participants who are between 4 weeks and 1 year post-transplant.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CYTOMEGALOVIRUS PROPHYLAXIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 0004)

    RECRUITING

    Chicago, Illinois, 60611, United States

    Contact Phone: •••-•••-••••

  • Children's Hospital Colorado ( Site 0013)

    RECRUITING

    Aurora, Colorado, 80045, United States

    Contact Phone: •••-•••-••••

  • Cincinnati Children's Hospital Medical Center ( Site 0002)

    RECRUITING

    Cincinnati, Ohio, 45229, United States

    Contact Phone: •••-•••-••••

  • Duke University Medical Center ( Site 0008)

    RECRUITING

    Durham, North Carolina, 27710, United States

    Contact Phone: •••-•••-••••

  • Lucile Packard Children's Hospital ( Site 0001)

    RECRUITING

    Palo Alto, California, 94304, United States

    Contact Phone: •••-•••-••••

  • Mayo Clinic - Rochester ( Site 0015)

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Phone: •••-•••-••••

  • Morgan Stanley Children's Hospital ( Site 0018)

    RECRUITING

    New York, New York, 10032, United States

    Contact Phone: •••-•••-••••

  • UCLA Clinical & Translational Research Center (CTRC) ( Site 0006)

    RECRUITING

    Los Angeles, California, 90095, United States

    Contact Phone: •••-•••-••••

  • UCSF Medical Center at Mission Bay ( Site 0017)

    RECRUITING

    San Francisco, California, 94158, United States

    Contact Phone: •••-•••-••••

  • University of California Davis Health ( Site 0023)

    RECRUITING

    Sacramento, California, 95817, United States

    Contact Phone: •••-•••-••••

  • University of Michigan ( Site 0014)

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.